Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Methylcrotonoyl chloride, also known as 3,3-dimethylacryloyl chloride, is a chemical compound that is a clear colorless to yellow liquid. It is known for its reactivity with various chemical groups, particularly silylketene acetals, and is used in the synthesis of various organic compounds.

3350-78-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3350-78-5 Structure
  • Basic information

    1. Product Name: 3-Methylcrotonoyl chloride
    2. Synonyms: 3-methyl-2-butenoylchlorid;3-METHYL-2-BUTENOYL CHLORIDE;3-METHYL-BUT-2-ENOYL CHLORIDE;3-METHYLCROTONOYL CHLORIDE;3,3-DIMETHYLACRYLOYL CHLORIDE;SENECIOYL CHLORIDE;3,3-Dimethylaclyloyl chloride;Methyl-3,3-Dimethyl
    3. CAS NO:3350-78-5
    4. Molecular Formula: C5H7ClO
    5. Molecular Weight: 118.56
    6. EINECS: 222-109-4
    7. Product Categories: Acid Halides;Building Blocks;Carbonyl Compounds;Chemical Synthesis;Organic Building Blocks;Isoquinolines ,Quinolines ,Quinazolines ,Quinaldines
    8. Mol File: 3350-78-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 145-147 °C(lit.)
    3. Flash Point: 124 °F
    4. Appearance: Clear colorless to yellow/Liquid
    5. Density: 1.065 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 4.73mmHg at 25°C
    7. Refractive Index: n20/D 1.476(lit.)
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. Water Solubility: reacts
    11. BRN: 1560268
    12. CAS DataBase Reference: 3-Methylcrotonoyl chloride(CAS DataBase Reference)
    13. NIST Chemistry Reference: 3-Methylcrotonoyl chloride(3350-78-5)
    14. EPA Substance Registry System: 3-Methylcrotonoyl chloride(3350-78-5)
  • Safety Data

    1. Hazard Codes: C
    2. Statements: 14-34-36/37-10
    3. Safety Statements: 26-36/37/39-45-16
    4. RIDADR: UN 2920 8/PG 2
    5. WGK Germany: 3
    6. RTECS:
    7. F: 10-19
    8. HazardClass: 3.2
    9. PackingGroup: III
    10. Hazardous Substances Data: 3350-78-5(Hazardous Substances Data)

3350-78-5 Usage

Uses

Used in Pharmaceutical Industry:
3-Methylcrotonoyl chloride is used as a synthetic intermediate for the production of various pharmaceutical compounds. It is particularly utilized in the synthesis of substituted 4,4-dimethyl-3,4-dihydro-1H-quinolin-2-one via condensation with aniline. 3-Methylcrotonoyl chloride has potential applications in the development of new drugs and therapies.
Used in Chemical Synthesis:
In the field of chemical synthesis, 3-Methylcrotonoyl chloride is used as a reagent for the preparation of N-(3,3-Dimethylacryloyl)-(S)-leucine methyl ester. 3-Methylcrotonoyl chloride serves as a key building block in the synthesis of complex organic molecules, which can be further utilized in various chemical and pharmaceutical applications.
Used in Organic Chemistry Research:
3-Methylcrotonoyl chloride is also used as a research tool in organic chemistry, where it is employed to study the reactivity of various functional groups and to develop new synthetic methods. Its ability to react with silylketene acetals in acetonitrile to give δ-ethylenic β-keto esters makes it a valuable compound for exploring novel reaction pathways and understanding the underlying mechanisms.

Check Digit Verification of cas no

The CAS Registry Mumber 3350-78-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,5 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3350-78:
(6*3)+(5*3)+(4*5)+(3*0)+(2*7)+(1*8)=75
75 % 10 = 5
So 3350-78-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H7ClO/c1-4(2)3-5(6)7/h3H,1-2H3

3350-78-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (183660)  3,3-Dimethylacryloylchloride  97%, contains 400 ppm phenothiazine as inhibitor

  • 3350-78-5

  • 183660-5G

  • 609.57CNY

  • Detail
  • Aldrich

  • (183660)  3,3-Dimethylacryloylchloride  97%, contains 400 ppm phenothiazine as inhibitor

  • 3350-78-5

  • 183660-25G

  • 1,881.36CNY

  • Detail

3350-78-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methylbut-2-enoyl chloride

1.2 Other means of identification

Product number -
Other names 3,3-Dimethylacrylyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3350-78-5 SDS

3350-78-5Synthetic route

3-Methylbutenoic acid
541-47-9

3-Methylbutenoic acid

3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane at 20℃;99%
With thionyl chloride at 0℃; for 3h;96%
With thionyl chloride 1.) reflux, 1.3 h, 2.) room temperature, 2.5 h, 3.) reflux, 1 h;92%
4,4-dimethyloxetan-2-one
1823-52-5

4,4-dimethyloxetan-2-one

3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

Conditions
ConditionsYield
With thionyl chloride Erhitzen des Reaktionsgemisches mit wenig Schwefelsaeure;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

i-Amyl alcohol
123-51-3

i-Amyl alcohol

3-methyl-1-butyl 3-methyl-2-butenoate
56922-73-7

3-methyl-1-butyl 3-methyl-2-butenoate

Conditions
ConditionsYield
With pyridine; dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 3.5h;100%
In benzene at 30℃; Kinetics; Activation energy; Further Variations:; Temperatures; Acylation; alcoholysis;
With pyridine; benzene
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

aniline
62-53-3

aniline

N-phenyl-3-methyl-2-butenamide
13209-80-8

N-phenyl-3-methyl-2-butenamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;100%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;100%
With pyridine97%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

diphenylphosphinous acid methyl ester
4020-99-9

diphenylphosphinous acid methyl ester

(3-Methyl-2-butenoyl)diphenylphosphanoxid
87951-17-5

(3-Methyl-2-butenoyl)diphenylphosphanoxid

Conditions
ConditionsYield
1) -196 deg C to r.t., 2) 2 h, r.t.;100%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

monohydroxymethyl-alpha-terthiophene
13059-93-3

monohydroxymethyl-alpha-terthiophene

5-(3-methyl-2-butenoyloxy)methyl-2,2':5',2''-terthiophene
26905-76-0

5-(3-methyl-2-butenoyloxy)methyl-2,2':5',2''-terthiophene

Conditions
ConditionsYield
With pyridine In dichloromethane100%
With pyridine In tetrahydrofuran 1.) 0 deg C, 3 h, 2.) reflux, 2h;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

(E)-trimethyl[2-(4-methylphenyl)ethenyl]silane
73839-45-9

(E)-trimethyl[2-(4-methylphenyl)ethenyl]silane

(E)-1-(4-methylphenyl)-3-oxo-5-methyl-1,4-hexadiene
73839-46-0

(E)-1-(4-methylphenyl)-3-oxo-5-methyl-1,4-hexadiene

Conditions
ConditionsYield
With aluminium trichloride In dichloromethane at -78℃; for 0.5h;100%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

2-methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane
14812-60-3

2-methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane

3-Methyl-1-(4,4,5,5-tetramethyl-2-oxo-2λ5-[1,3,2]dioxaphospholan-2-yl)-but-2-en-1-one

3-Methyl-1-(4,4,5,5-tetramethyl-2-oxo-2λ5-[1,3,2]dioxaphospholan-2-yl)-but-2-en-1-one

Conditions
ConditionsYield
at 0 - 35℃; for 4h;100%
for 1h; Yield given;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

4-bromo-aniline
106-40-1

4-bromo-aniline

N-(3,3'-dimethylacryoloyl)-4-bromoaniline
135631-89-9

N-(3,3'-dimethylacryoloyl)-4-bromoaniline

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 3.33333h;100%
Stage #1: 3,3-Dimethylacryloyl chloride; 4-bromo-aniline In dichloromethane at 20℃; for 0.333333h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 3h;
100%
With pyridine at 0 - 20℃; for 5h; Inert atmosphere;99%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

(R)-3-benzyloxy-1,2-propanediol
56552-80-8

(R)-3-benzyloxy-1,2-propanediol

1,2-di(3-methylbut-2-enoyl)-3-benzyl-sn-glycerol
349123-42-8

1,2-di(3-methylbut-2-enoyl)-3-benzyl-sn-glycerol

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 0 - 20℃;100%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

4-bromo-N-methylaniline
6911-87-1

4-bromo-N-methylaniline

N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide
345964-72-9

N-(4-bromophenyl)-N-methyl-3-methyl-2-butenamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 2.5h;100%
With triethylamine In dichloromethane
With triethylamine In dichloromethane at 20℃; for 2.5h;
With triethylamine In dichloromethane for 2.58333h;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

(+/-)-2-methyl-1-butanol
137-32-6

(+/-)-2-methyl-1-butanol

2-methylbutyl 3-methyl-2-butenoate

2-methylbutyl 3-methyl-2-butenoate

Conditions
ConditionsYield
With pyridine; dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 3.5h;100%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

pentan-1-ol
71-41-0

pentan-1-ol

pentyl 3-methyl-2-butenoate

pentyl 3-methyl-2-butenoate

Conditions
ConditionsYield
With pyridine; dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 3.5h;99.7%
In benzene at 30℃; Kinetics; Activation energy; Further Variations:; Temperatures; Acylation; alcoholysis;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

Geraniol
106-24-1

Geraniol

(E)-geranyl 3-methyl-3-butenoate
84825-22-9

(E)-geranyl 3-methyl-3-butenoate

Conditions
ConditionsYield
With triethylamine In dichloromethane at -78℃; for 3h;99%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

tert-butyl pyrrolidine-1-carboxylate
86953-79-9

tert-butyl pyrrolidine-1-carboxylate

N-(tert-butoxycarbonyl)-2-(1-oxopropyl)pyrrolidine

N-(tert-butoxycarbonyl)-2-(1-oxopropyl)pyrrolidine

Conditions
ConditionsYield
With sec.-butyllithium; (-)-sparteine In tetrahydrofuran at -78℃; for 2h; Product distribution; other reag.;99%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

tert-butyl pyrrolidine-1-carboxylate
86953-79-9

tert-butyl pyrrolidine-1-carboxylate

N-(tert-butoxycarbonyl)-2-[3-methyl-1-oxo-2-butenyl]pyrrolidine

N-(tert-butoxycarbonyl)-2-[3-methyl-1-oxo-2-butenyl]pyrrolidine

Conditions
ConditionsYield
Stage #1: tert-butyl pyrrolidine-1-carboxylate With sec.-butyllithium; (-)-sparteine In tetrahydrofuran at -78℃; for 1h;
Stage #2: With lithium chloride In tetrahydrofuran at -55℃; for 1h;
Stage #3: 3,3-Dimethylacryloyl chloride In tetrahydrofuran at -50 - 20℃;
99%
With sec.-butyllithium; (-)-sparteine 1.) THF, -78 deg C; Yield given;
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

(S)-4-phenyl-2-oxazolidinone
99395-88-7

(S)-4-phenyl-2-oxazolidinone

(S)-3-(3-Methyl-but-2-enoyl)-4-phenyl-oxazolidin-2-one
294176-63-9

(S)-3-(3-Methyl-but-2-enoyl)-4-phenyl-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (S)-4-phenyl-2-oxazolidinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5h; Metallation;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran; hexane at -78 - 0℃; for 3.5h; Acylation;
99%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

2-Bromo-4-(5-hydroxy-3-methyl-pyrazol-1-yl)-benzonitrile
1008520-71-5

2-Bromo-4-(5-hydroxy-3-methyl-pyrazol-1-yl)-benzonitrile

2-Bromo-4-[5-hydroxy-3-methyl-4-(3-methyl-but-2-enoyl)-pyrazol-1-yl]-benzonitrile
1008520-72-6

2-Bromo-4-[5-hydroxy-3-methyl-4-(3-methyl-but-2-enoyl)-pyrazol-1-yl]-benzonitrile

Conditions
ConditionsYield
Stage #1: 2-Bromo-4-(5-hydroxy-3-methyl-pyrazol-1-yl)-benzonitrile With magnesium ethylate In tetrahydrofuran for 4h; Heating / reflux;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran at 0 - 20℃;
Stage #3: With hydrogenchloride; water In tetrahydrofuran at 0℃; for 0.25h;
99%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

(R)-4-(phenylmethyl)-2-oxazolidinone
40217-17-2, 90719-32-7, 120574-96-1, 102029-44-7

(R)-4-(phenylmethyl)-2-oxazolidinone

(R)-4-Benzyl-3-(3-methyl-but-2-enoyl)-oxazolidin-2-one

(R)-4-Benzyl-3-(3-methyl-but-2-enoyl)-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (R)-4-(phenylmethyl)-2-oxazolidinone With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.166667h; Inert atmosphere;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran; hexane at -78 - 0℃; for 0.5h; Inert atmosphere;
99%
Stage #1: (R)-4-(phenylmethyl)-2-oxazolidinone With n-butyllithium In tetrahydrofuran for 0.166667h; Inert atmosphere; Cooling;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran at 0℃; for 0.5h; Inert atmosphere; Cooling;
51.1 g
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

amino-5-bromo-2-toluene
6933-10-4

amino-5-bromo-2-toluene

N-(4-bromo-2-methylphenyl)-3-methyl-2-butenamide
203856-43-3

N-(4-bromo-2-methylphenyl)-3-methyl-2-butenamide

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water98.6%
With sodium hydroxide In dichloromethane at 20℃; for 16h; Acylation;65%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

p-cresol
106-44-5

p-cresol

4'-methylphenyl 3-methylbut-2-enoate
24700-20-7

4'-methylphenyl 3-methylbut-2-enoate

Conditions
ConditionsYield
Stage #1: p-cresol With sodium hydride In tetrahydrofuran at 0℃; for 0.25h;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran at 0 - 20℃; for 3h;
98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

1,2-dimethoxybenzene
91-16-7

1,2-dimethoxybenzene

1-(3,4-dimethoxyphenyl)-3-methylbut-2-en-1-one

1-(3,4-dimethoxyphenyl)-3-methylbut-2-en-1-one

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane at 0℃; for 3h; Inert atmosphere;98%
With aluminium trichloride; diethyl ether
With aluminum (III) chloride In dichloromethane
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

4,6-dimethoxyindole
23659-87-2

4,6-dimethoxyindole

1-(4',6'-dimethoxyindol-1'-yl)-3-methylbut-2-en-1-one
151290-63-0

1-(4',6'-dimethoxyindol-1'-yl)-3-methylbut-2-en-1-one

Conditions
ConditionsYield
With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate for 2h; Ambient temperature;98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

diallylamine
124-02-7

diallylamine

3-methylbut-2-enoic acid diallylamide
82799-51-7

3-methylbut-2-enoic acid diallylamide

Conditions
ConditionsYield
With triethylamine In benzene98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

3-Methyl-6-nitro-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepine
189939-48-8

3-Methyl-6-nitro-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepine

3-Methyl-1-(3-methyl-6-nitro-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl)-but-2-en-1-one
189939-49-9

3-Methyl-1-(3-methyl-6-nitro-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl)-but-2-en-1-one

Conditions
ConditionsYield
With dmap; sodium hydrogencarbonate for 3h;98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

benzyl-(2-tert-butyl-phenyl)-amine
205242-33-7

benzyl-(2-tert-butyl-phenyl)-amine

N-benzyl-N-(2-tert-butylphenyl)-3,3-dimethylacrylamide
205242-34-8

N-benzyl-N-(2-tert-butylphenyl)-3,3-dimethylacrylamide

Conditions
ConditionsYield
In benzene for 24h;98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

2,2,2-trifluoroethanol
75-89-8

2,2,2-trifluoroethanol

2,2,2-trifluoroethyl 3-methylbut-2-enoate
796850-91-4

2,2,2-trifluoroethyl 3-methylbut-2-enoate

Conditions
ConditionsYield
With triethylamine In diethyl ether at 0℃; for 4h;98%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

3-methyl-2-buten-1-ol
556-82-1

3-methyl-2-buten-1-ol

3-methyl-2-buten-1-yl 3-methyl-2-butenoate
72779-06-7

3-methyl-2-buten-1-yl 3-methyl-2-butenoate

Conditions
ConditionsYield
With pyridine; dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 3.5h;97.9%
With pyridine; benzene
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

tryptamine
61-54-1

tryptamine

N-(2-(1H-indol-3-yl)-ethyl)-3-methylbut-2-enamide
87078-46-4

N-(2-(1H-indol-3-yl)-ethyl)-3-methylbut-2-enamide

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane In tetrahydrofuran for 48h; Inert atmosphere;97.4%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

3-methyl-phenol
108-39-4

3-methyl-phenol

3'-methylphenyl 3-methylbut-2-enoate
133532-17-9

3'-methylphenyl 3-methylbut-2-enoate

Conditions
ConditionsYield
Stage #1: 3-methyl-phenol With sodium hydride In tetrahydrofuran at 0℃; for 0.25h;
Stage #2: 3,3-Dimethylacryloyl chloride In tetrahydrofuran at 0 - 20℃; for 3h;
97%
3,3-Dimethylacryloyl chloride
3350-78-5

3,3-Dimethylacryloyl chloride

copper(I) cyanide
544-92-3

copper(I) cyanide

senecioyl cyanide
38576-60-2

senecioyl cyanide

Conditions
ConditionsYield
In acetone for 0.416667h; Heating;97%
In acetonitrile at 90℃; for 1.5h;59%
With phosphorus pentoxide In benzene for 6h; Heating;51%
In acetonitrile
In acetonitrile for 0.5h; Heating;

3350-78-5Relevant articles and documents

Enantioselective total synthesis of (+)-scuteflorin A using organocatalytic asymmetric epoxidation

Bartlett, Christopher J.,Day, David P.,Chan, Yohan,Allin, Steven M.,McKenzie, Michael J.,Slawin, Alexandra M. Z.,Bulman Page, Philip C.

, p. 772 - 774 (2012)

We report the first enantioselective total synthesis of (+)-scuteflorin A in 14% overall yield, employing a chiral iminium salt to effect an organocatalytic asymmetric epoxidation of xanthyletin in >99% ee as the key step.

Masked Amino Trimethyl Lock (H2N-TML) Systems: New Molecular Entities for the Development of Turn-On Fluorophores and Their Application in Hydrogen Sulfide (H2S) Imaging in Human Cells

Jimidar, Claire Cheyenne,Grunenberg, J?rg,Karge, Bianka,Fuchs, Hazel Leanne Sarah,Br?nstrup, Mark,Klahn, Philipp

supporting information, (2021/11/10)

Masked trimethyl lock (TML) systems as molecular moieties enabling the bioresponsive release of compounds or dyes in a controlled temporal and spatial manner have been widely applied for the development of drug conjugates, prodrugs or molecular imaging tools. Herein, we report the development of a novel amino trimethyl lock (H2N-TML) system as an auto-immolative molecular entity for the release of fluorophores. We designed Cou-TML-N3 and MURh-TML-N3, two azide-masked turn-on fluorophores. The latter was demonstrated to selectively release fluorescent MURh in the presence of physiological concentrations of the redox-signaling molecule H2S in vitro and was successfully applied to image H2S in human cells.

Synthesis of sorbicillinoid analogues with anti-inflammation activities

Ding, Wenjuan,Li, Xiaosan,Tang, Jinshan,Tian, Danmei,Wang, Fangfang,Xu, Zhipeng,Zhang, Meng,Zhang, Youwei

, (2022/01/06)

Recently, we demonstrated potential anti-inflammatory effects of sorbicillinoids isolated from marine fungi. Here, we report the synthesis of a series of new sorbicillinoid analogues and assessed their anti-inflammatory activities. Our results reveal that side chain substitution with (E)-2-butenoyl, (E)-3-(4-fluorophenyl)-2-propenoyl, and (E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl significantly enhanced the inhibitory effects of the derivatives on nitric oxide (NO) production and inducible NO synthesis (iNOS) expression stimulated by lipopolysaccharides (LPS) in mouse macrophage. Further chemical derivatization shows that the monomethylresorcinol skeleton worked better than the dimethylresorcinol skeleton in inhibiting LPS-induced inflammatory response in cultured cells. Among the 29 synthesized sorbicillinoid analogues, compounds 4b and 12b exhibited the strongest anti-inflammatory activities, holding the promise of being developed into lead compounds that can be explored as potent anti-inflammation agents.

Synthesis of Succinimides via Intramolecular Alder-Ene Reaction of 1,6-Enynes

Chen, Xia,Lu, Yuling,Guan, Zhenhua,Gu, Lianghu,Chen, Chunmei,Zhu, Hucheng,Luo, Zengwei,Zhang, Yonghui

supporting information, p. 3173 - 3178 (2021/05/05)

A novel and convenient method has been developed for the facile synthesis of functionalized succinimide derivatives via intramolecular Alder-ene reaction of 1,6-enynes. This reaction features mild and metal-free reaction conditions, which offers a green and efficient entry to synthetically important succinimide scaffolds. Preliminary mechanistic studies suggest that a diradical intermediate might be involved in this transformation.

Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells

Zhao, Bingbing,Zhao, Chengwu,Hu, Xiaohan,Xu, Shan,Lan, Zhou,Guo, Yuping,Yang, Zunhua,Zhu, Wufu,Zheng, Pengwu

, (2019/11/03)

Four series of thiopyranopyrimidine AZD9291 derivatives containing acrylamide structure were designed, synthesized and evaluated for their antiproliferative activity against A549 and Hela cancer cells. Most of the compounds exhibited excellent antiproliferative activity against A549 cells. Moreover, the compounds with indole ring fluorine substituted exhibited better antiproliferative activity against Hela cells. The most promising compound 23g exhibited excellent enzymatic inhibitory activity and selectivity for EGFRL858R/T790M double mutations. The IC50 value against EGFRL858R/T790M kinase was 16 nM. The compound 23g inhibits selectively against the mutated form of EGFR, with the selectivity more than 125-fold. Furthermore, compound 23g also inhibited A549 cells, Hela cells and H1975 cells proliferation at a low concentration, and the IC50 values were 0.057 μM, 0.104 μM and 0.916 μM, respectively. To further investigate the QSARs of thiopyranopyrimidine derivatives, the CoMFA (q [2] = 0.765, r2 = 0.965) and CoMSIA (q [2] = 0.875, r2 = 0.956) models on Hela cancer cells were established. The generated 3D-QSAR model was validated to be reliable and can be used for further design and optimization of novel and selective EGFR inhibitors.

Design, synthesis and biological evaluation of AZD9291 derivatives as selective and potent EGFRL858R/T790M inhibitors

Zhao, Bingbing,Xiao, Zhen,Qi, Jianguo,Luo, Rong,Lan, Zhou,Zhang, Yanzhuo,Hu, Xiaohan,Tang, Qidong,Zheng, Pengwu,Xu, Shan,Zhu, Wufu

, p. 367 - 380 (2018/12/13)

Third-generation epidermal growth factor receptor (EGFR)L858R/T790M inhibitors are still the main drugs for the treatment of advanced non-small cell lung cancer (NSCLC), and these drugs have achieved remarkable clinical efficacy. However, there are still many patients suffering from drug-resistant mutations and drug side effects caused by NSCLC. In this study, guided by the molecular simulation, we applied a structure-based drug design strategy (SBDD) and optimized the structure to obtain a series of potent and selective EGFRL858R/T790M inhibitors. The most potent compound 18e demonstrated excellent kinase inhibitory activity and selectivity for EGFRL858R/T790M double mutants and the IC50 value reached nanomolar level. The selectivity of 18e against wild-type EGFR was near to 200-fold. In addition, compound 18e also inhibited H1975 cells proliferation at G2/M phase and induced apoptosis at a concentration of 0.25 μM, which makes it more valuable for potential lung cancer research.

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors

OuYang, Yiqiang,Zou, Wensheng,Peng, Liang,Yang, Zunhua,Tang, Qidong,Chen, Mengzi,Jia, Shuang,Zhang, Hong,Lan, Zhou,Zheng, Pengwu,Zhu, Wufu

, p. 29 - 43 (2018/05/24)

Eight series of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, MCF-7 and PC-3). Most of the forty nine target compounds showed excellent antiproliferative activity against one or several cancer cell lines. The compound 13a showed the best activity against A549, MCF-7 and PC-3 cancer cell lines, with the IC50 values of 1.09 ± 0.04 μM, 1.34 ± 0.13 μM and 1.23 ± 0.09 μM, respectively. Eight selected compounds were further selected to evaluated for the inhibitory activity against EGFR kinase. Three of them showed equal activity against EGFR kinase to positive control afatinib. AnnexinV-FITC, propidium iodide (PI) double staining and acridine orange single staining results indicated that the compound 13a could induce apoptosis of human lung cancer A549 cells.

Synthesis, Reactivity, Functionalization, and ADMET Properties of Silicon-Containing Nitrogen Heterocycles

Barraza, Scott J.,Denmark, Scott E.

supporting information, p. 6668 - 6684 (2018/06/12)

Silicon-containing compounds have been largely ignored in drug design and development, despite their potential to improve not only the potency but also the physicochemical and ADMET (absorption, distribution, metabolism, excretion, toxicity) properties of drug-like candidates because of the unique characteristics of silicon. This deficiency is in large part attributable to a lack of general methods for synthesizing diverse organosilicon structures. Accordingly, a new building block strategy has been developed that diverges from traditional approaches to incorporation of silicon into drug candidates. Flexible, multi-gram-scale syntheses of silicon-containing tetrahydroquinoline and tetrahydroisoquinoline building blocks are described, along with methods by which diversely functionalized silicon-containing nitrogen heterocycles can be rapidly built using common reactions optimized to accommodate the properties of silicon. Furthermore, to better clarify the liabilities and advantages of silicon incorporation, select compounds and their carbon analogues were challenged in ADMET-focused biological studies.

Design and Synthesis of Natural Product Inspired Libraries Based on the Three-Dimensional (3D) Cedrane Scaffold: Toward the Exploration of 3D Biological Space

Tajabadi, Fatemeh Mazraati,Pouwer, Rebecca H.,Liu, Miaomiao,Dashti, Yousef,Campitelli, Marc R.,Murtaza, Mariyam,Mellick, George D.,Wood, Stephen A.,Jenkins, Ian D.,Quinn, Ronald J.

, p. 6609 - 6628 (2018/07/25)

A chemoinformatic method was developed to extract nonflat scaffolds embedded in natural products within the Dictionary of Natural Products (DNP). The cedrane scaffold was then chosen as an example of a nonflat scaffold that directs substituents in three-dimensional (3D) space. A cedrane scaffold that has three orthogonal handles to allow generation of 1D, 2D, and 3D libraries was synthesized on a large scale. These libraries would cover more than 50% of the natural diversity of natural products with an embedded cedrane scaffold. Synthesis of three focused natural product-like libraries based on the 3D cedrane scaffold was achieved. A phenotypic assay was used to test the biological profile of synthesized compounds against normal and Parkinson's patient-derived cells. The cytological profiles of the synthesized analogues based on the cedrane scaffold revealed that this 3D scaffold, prevalidated by nature, can interact with biological systems as it displayed various effects against normal and Parkinson's patient-derived cell lines.

ISOSAMIDIN ANALOG AND SAMIDIN ANALOG PRODUCTION METHOD

-

Paragraph 0083, (2018/10/19)

PROBLEM TO BE SOLVED: To provide a simple method of industrial-scale production of an isosamidin analog or samidin analog. SOLUTION: In the production method, a compound represented by the formula (1) in the figure is 1) senecioylated and 2) acetylated. [X is O or the like; R1 are each independently a C1-3 alkyl group or the like; R2 is H or the like; R3 are each a C1-3 alkyl group; m is an integer from 0 to 2; n is 1 or 2; and the symbol * represents an asymmetric center.] SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3350-78-5